<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1756" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1756/" /><meta name="ncbi_pagename" content="Shwachman-Diamond Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Shwachman-Diamond Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Shwachman-Diamond Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/18" /><meta name="citation_author" content="Adam Nelson" /><meta name="citation_author" content="Kasiani Myers" /><meta name="citation_pmid" content="20301722" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1756/" /><meta name="citation_keywords" content="Shwachman-Bodian-Diamond Syndrome" /><meta name="citation_keywords" content="Shwachman-Bodian-Diamond Syndrome" /><meta name="citation_keywords" content="DnaJ homolog subfamily C member 21" /><meta name="citation_keywords" content="Elongation factor-like GTPase 1" /><meta name="citation_keywords" content="Ribosome maturation protein SBDS" /><meta name="citation_keywords" content="Signal recognition particle 54 kDa protein" /><meta name="citation_keywords" content="DNAJC21" /><meta name="citation_keywords" content="EFL1" /><meta name="citation_keywords" content="SBDS" /><meta name="citation_keywords" content="SRP54" /><meta name="citation_keywords" content="Shwachman-Diamond Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Shwachman-Diamond Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Adam Nelson" /><meta name="DC.Contributor" content="Kasiani Myers" /><meta name="DC.Date" content="2018/10/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1756/" /><meta name="description" content="Shwachman-Diamond syndrome (SDS) is characterized by: exocrine pancreatic dysfunction with malabsorption, malnutrition, and growth failure; hematologic abnormalities with single- or multilineage cytopenias and susceptibility to myelodysplasia syndrome (MDS) and acute myelogeneous leukemia (AML); and bone abnormalities. In almost all affected children, persistent or intermittent neutropenia is a common presenting finding, often before the diagnosis of SDS is made. Short stature and recurrent infections are common." /><meta name="og:title" content="Shwachman-Diamond Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Shwachman-Diamond syndrome (SDS) is characterized by: exocrine pancreatic dysfunction with malabsorption, malnutrition, and growth failure; hematologic abnormalities with single- or multilineage cytopenias and susceptibility to myelodysplasia syndrome (MDS) and acute myelogeneous leukemia (AML); and bone abnormalities. In almost all affected children, persistent or intermittent neutropenia is a common presenting finding, often before the diagnosis of SDS is made. Short stature and recurrent infections are common." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1756/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sds/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1756/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BE092DFC77C910000000005E402C1.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1756_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1756_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sgs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sft/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1756_"><span class="title" itemprop="name">Shwachman-Diamond Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Shwachman-Bodian-Diamond Syndrome</div><p class="contrib-group"><span itemprop="author">Adam Nelson</span>, MBBS and <span itemprop="author">Kasiani Myers</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1756_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1756_ai__"><div class="contrib half_rhythm"><span itemprop="author">Adam Nelson</span>, MBBS<div class="affiliation small">Assistant Professor of Pediatrics, Division of Blood and Marrow Transplantation and Immune Deficiency<br />The Cancer and Blood Diseases Institute<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@noslen.mada" class="oemail">gro.cmhcc@noslen.mada</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kasiani Myers</span>, MD<div class="affiliation small">Assistant Professor of Pediatrics, Division of Blood and Marrow Transplantation and Immune Deficiency<br />The Cancer and Blood Diseases Institute<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@sreym.inaisak" class="oemail">gro.cmhcc@sreym.inaisak</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 17, 2008</span>; Last Update: <span itemprop="dateModified">October 18, 2018</span>.</p><p><em>Estimated reading time: 33 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sds.Summary" itemprop="description"><h2 id="_sds_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Shwachman-Diamond syndrome (SDS) is characterized by: exocrine pancreatic dysfunction with malabsorption, malnutrition, and growth failure; hematologic abnormalities with single- or multilineage cytopenias and susceptibility to myelodysplasia syndrome (MDS) and acute myelogeneous leukemia (AML); and bone abnormalities. In almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, persistent or intermittent neutropenia is a common presenting finding, often before the diagnosis of SDS is made. Short stature and recurrent infections are common.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SDS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the classic clinical findings of exocrine pancreatic dysfunction and bone marrow dysfunction and/or by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>DNAJC21</i>, <i>EFL1</i>, or <i>SBDS</i>, or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SRP54.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Care by a multidisciplinary team is recommended. Exocrine pancreatic insufficiency is treated with oral pancreatic enzymes and fat-soluble vitamin supplementation. Blood and/or platelet transfusions may be considered for anemia and/or thrombocytopenia associated with bi- or trilineage cytopenia. If recurrent infections are severe and absolute neutrophil counts are persistently &#x02264;500/mm<sup>3</sup>, treatment with granulocyte-colony stimulation factor (G-CSF) can be considered. Hematopoietic stem cell transplantation (HSCT) should be considered for treatment of severe pancytopenia, MDS, or AML.</p><p><i>Prevention of secondary complications:</i> Aggressive dental hygiene should be pursued to promote oral health. Consider prophylactic antibiotics and G-CSF to reduce risk of infection during complex dental procedures or orthopedic surgery.</p><p><i>Surveillance:</i> Complete blood counts at least every three to six months; assessment of development, growth, and nutritional status every six months. Following baseline examination, repeat bone marrow examination every one to three years or more frequently if bone marrow changes are observed. Monitor for orthopedic complications with x-rays of hips and knees during the most rapid growth stages. Perform bone densitometry before puberty, during puberty, and thereafter based on individual findings. Perform neuropsychological screening in children age 6-8 years, 11-13 years, and 15-17 years.</p><p><i>Agents/circumstances to avoid:</i> Prolonged use of cytokine and hematopoietic growth factors (e.g., G-CSF) should be considered with caution. Some drugs used in standard HSCT preparative regimens (e.g., cyclophosphamide and busulfan) may not be suitable because of possible cardiac toxicity.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (most commonly) or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><ul><li class="half_rhythm"><div><i>Autosomal recessive SDS.</i> SDS caused by pathogenic variants in <i>DNAJC21</i>, <i>EFL1</i>, or <i>SBDS</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Most parents of children with autosomal recessive SDS are heterozygotes (carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>); however, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants have been reported. When both parents are known to be carriers, the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> have a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an unaffected <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for relatives at risk is possible if both pathogenic variants in a family are known.</div></li><li class="half_rhythm"><div><i>Autosomal dominant SDS.</i> SDS caused by pathogenic variants in <i>SRP54</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; most such <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date have resulted from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SRP54</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p>Prenatal testing for pregnancies at increased risk and preimplantation diagnosis are possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in a family are known.</p></div></div><div id="sds.Diagnosis"><h2 id="_sds_Diagnosis_">Diagnosis</h2><div id="sds.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Shwachman-Diamond syndrome (SDS) <b>should be suspected</b> in individuals with some or all of the following clinical findings.</p><p><b>Exocrine pancreatic dysfunction,</b> documented with any one of the following:</p><ul><li class="half_rhythm"><div>Low serum concentrations of the digestive enzymes pancreatic isoamylase and cationic trypsinogen, adjusted to age&#x000a0;*</div></li><li class="half_rhythm"><div>Low levels of fecal elastase</div></li><li class="half_rhythm"><div>Supportive features including:</div><ul><li class="half_rhythm"><div>An abnormal fecal fat balance study of a 72-hour stool collection (with exclusion of intestinal mucosal disease or cholestatic liver disease)</div></li><li class="half_rhythm"><div>Evidence of pancreatic lipomatosis on imaging</div></li><li class="half_rhythm"><div>Reduced levels of fat-soluble vitamins (A, D, E, K)</div></li></ul></li></ul><p>* Note: Exocrine pancreatic dysfunction may be difficult to detect because the production of individual pancreatic enzymes varies during childhood and because severe perturbations of enzyme levels are required to meet diagnostic criteria [<a class="bk_pop" href="#sds.REF.schibli.2006.90">Schibli et al 2006</a>]. Additionally:</p><ul><li class="half_rhythm"><div>Serum pancreatic isoamylase concentration is not reliable in children younger than age three years [<a class="bk_pop" href="#sds.REF.ip.2002.259">Ip et al 2002</a>].</div></li><li class="half_rhythm"><div>Serum cationic trypsinogen concentration increases to pancreatic-sufficient levels during early childhood in approximately 50% of children with SDS [<a class="bk_pop" href="#sds.REF.durie.2004">Durie &#x00026; Rommens 2004</a>].</div></li></ul><p><b>Hematologic abnormalities caused by bone marrow dysfunction</b> and involving one or more of the following:</p><ul><li class="half_rhythm"><div>Hypoproductive cytopenias. Persistent or intermittent depression of at least one lineage (for &#x02265;2 measurements taken over a period of &#x02265;3 months):</div><ul><li class="half_rhythm"><div>Neutropenia (absolute neutrophil count &#x0003c;1,500 neutrophils/mm<sup>3</sup>)</div></li><li class="half_rhythm"><div>Thrombocytopenia (platelet count &#x0003c;150,000 platelets/mm<sup>3</sup>)</div></li><li class="half_rhythm"><div>Anemia or macrocytosis (with hemoglobin concentration below normal range for age)</div></li></ul></li><li class="half_rhythm"><div>Pancytopenia. Trilineage cytopenia with persistent neutropenia, thrombocytopenia, and anemia</div></li><li class="half_rhythm"><div>Abnormal findings on bone marrow examination:</div><ul><li class="half_rhythm"><div>Varying degrees of hypocellularity and fatty infiltration of the marrow compartments for age, indicating marrow failure and disordered hematopoiesis</div></li><li class="half_rhythm"><div>Aplastic anemia and/or myelodysplasia with or without abnormal <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> findings (which can include <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 20q11, <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7, isochromosome 7, or other chromosomal changes seen in bone marrow failure syndromes).</div></li><li class="half_rhythm"><div>Leukemia. In particular acute myleogenous leukemia</div></li></ul></li></ul><p><b>Other primary features</b> [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>]:</p><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Skeletal abnormalities, most commonly chondrodysplasia or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> thoracic dystrophy</div></li><li class="half_rhythm"><div>Congenital anomalies including cardiac defects, ear malformations / hearing loss, or skin rashes</div></li><li class="half_rhythm"><div>Hepatomegaly with or without elevation of serum aminotransferase levels</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul></div><div id="sds.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SDS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the classic clinical findings of exocrine pancreatic dysfunction and bone marrow failure and/or identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>DNAJC21</i>, <i>EFL1</i>, or <i>SBDS</i>, or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SRP54</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1756/table/sds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsdsTmoleculargenetictestingusedin" rid-ob="figobsdsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: Although the diagnosis of SDS has classically relied on evidence of exocrine pancreatic dysfunction and bone marrow failure with single- or multilineage cytopenia [<a class="bk_pop" href="#sds.REF.rothbaum.2002.266">Rothbaum et al 2002</a>, <a class="bk_pop" href="#sds.REF.dror.2011.40">Dror et al 2011</a>, <a class="bk_pop" href="#sds.REF.myers.2013a.117">Myers et al 2013a</a>], a publication based on the North American <a href="http://sdsregistry.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SDS Registry</a> reported that almost half of the 37 individuals with genetically confirmed SDS did not have this classic combination of manifestations [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>], indicating that the phenotypic spectrum of SDS is broader than previously thought, leading to underdiagnosis when the diagnosis is based on clinical findings alone. <a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al [2014]</a> found that the features supporting the diagnosis of SDS in individuals with neutropenia included bone marrow abnormalities (hypocellularity, dysplasias, and clonality for <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 20q11), as well as the presence of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance of SDS.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SDS is broad, individuals with the distinctive findings described in <a href="#sds.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#sds.Option_1">Option 1</a>), whereas those in whom the diagnosis of SDS has not been considered are more likely to be diagnosed using genomic testing (see <a href="#sds.Option_2">Option 2</a>).</p><div id="sds.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of SDS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>concurrent</b> or <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Concurrent or serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> If available, concurrent testing of all the genes known to be associated with SDS (see <a class="figpopup" href="/books/NBK1756/table/sds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsdsTmoleculargenetictestingusedin" rid-ob="figobsdsTmoleculargenetictestingusedin">Table 1</a>) is recommended. Sequence analysis detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</p><p>Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</p><p>Alternatively, serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing can be done starting with <i>SBDS</i>, the gene most commonly associated with SDS. If testing of <i>SBDS</i> is not diagnostic, the other three genes can be tested in any order.</p><div id="sds.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.Td_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:top;"><b>Note:</b> Analysis of <i>SBDS</i> is complicated by the presence of a highly homologous <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>, <i>SBDSP</i>. Common pathogenic variants in the active <i>SBDS</i> arise from <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> and <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with the <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> (see <a href="#sds.Molecular_Genetics">Molecular Genetics</a>).</td></tr></tbody></table></div></div><p>Targeted analysis for the three common <i>SBDS</i> pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2, which are derived from <i>SBDS</i>, can be performed first:</p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1756/table/sds.T.sbds_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figsdsTsbdspathogenicvariantsdiscussed" rid-ob="figobsdsTsbdspathogenicvariantsdiscussed">c.183_184delinsCT</a></div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1756/table/sds.T.sbds_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figsdsTsbdspathogenicvariantsdiscussed" rid-ob="figobsdsTsbdspathogenicvariantsdiscussed">c.258+2T&#x0003e;C</a></div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1756/table/sds.T.sbds_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figsdsTsbdspathogenicvariantsdiscussed" rid-ob="figobsdsTsbdspathogenicvariantsdiscussed">c.[183_184delinsCT; 258+2T&#x0003e;C]</a> (a complex <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> resulting from <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with <i>SBDSP</i>)</div></li></ul><p>Targeted testing of <i>SBDS</i> detects at least one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and both pathogenic variants in approximately 62% of affected individuals who have SDS associated with <i>SBDS</i> [<a class="bk_pop" href="#sds.REF.boocock.2003.97">Boocock et al 2003</a>].</p><p>Note: Because the complex c.[183_184delinsCT; 258+2T&#x0003e;C] <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> event, parental testing is needed to distinguish:</p><ul><li class="half_rhythm"><div>In <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration (i.e., c.[183_184delinsCT; 258+2T&#x0003e;C] on the same <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>)</div><div>FROM</div></li><li class="half_rhythm"><div>In <a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a> configuration (i.e., c.183_184delinsCT on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and c.258+2T&#x0003e;C on the other allele)</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>DNAJC21</i>, <i>EFL1</i>, <i>SBDS</i>, <i>SRP54</i>, and other genes of interest (see <a href="#sds.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview.</i> (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1756/table/sds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsdsTmoleculargenetictestingusedin" rid-ob="figobsdsTmoleculargenetictestingusedin">Table 1</a>).</p><div id="sds.Te" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.Te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.Te_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:top;"><b>Note:</b> Analysis of <i>SBDS</i> is complicated by the presence of a highly homologous <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>, <i>SBDSP</i>. Common pathogenic variants in the active <i>SBDS</i> arise from <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> and <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with the <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> (see <a href="#sds.Molecular_Genetics">Molecular Genetics</a>). A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> not specifically designed for SDS or <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis may not detect common <i>SDBS</i> pathogenic variants, although pathogenic variants in one of the other genes could be detected.</td></tr></tbody></table></div></div><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="sds.Option_2"><h4>Option 2</h4><p>When the diagnosis of SDS is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which genes are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><div id="sds.Tf" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.Tf/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.Tf_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:top;"><b>Note:</b> Analysis of <i>SBDS</i> is complicated by the presence of a highly homologous <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>, <i>SBDSP</i>. Common pathogenic variants in the active <i>SBDS</i> arise from <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> and <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with the <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> (see <a href="#sds.Molecular_Genetics">Molecular Genetics</a>). Exome analysis may not detect common <i>SDBS</i> pathogenic variants although pathogenic variants in one of the other genes could be detected.</td></tr></tbody></table></div></div><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="sds.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Shwachman-Diamond Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of SDS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EFL1</i></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/6&#x000a0;<sup>6</sup></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNAJC21</i></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/4&#x000a0;<sup>8</sup></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/4&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SBDS</i></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~92%</td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>9</sup></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2%&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SRP54</i></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3&#x000a0;<sup>11</sup></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10%</td><td headers="hd_h_sds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_sds.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sds.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="sds.TF.1.2"><p class="no_margin">See <a href="/books/NBK1756/#sds.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="sds.TF.1.3"><p class="no_margin">See <a href="#sds.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="sds.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="sds.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, and multiplex ligation-dependent probe amplification (MLPA) and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Assay design is complicated by the presence of <i>SBDSP</i>.</p></div></dd><dt>6. </dt><dd><div id="sds.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#sds.REF.stepensky.2017.558">Stepensky et al [2017]</a></p></div></dd><dt>7. </dt><dd><div id="sds.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="sds.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#sds.REF.dhanraj.2017.1557">Dhanraj et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="sds.TF.1.9"><p class="no_margin">Rare pathogenic variants, such as c.297_300delAAGA, are also likely the consequence of <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with <i>SBDSP</i> [<a class="bk_pop" href="#sds.REF.carvalho.2014.64">Carvalho et al 2014</a>; J Rommens, personal communication].</p></div></dd><dt>10. </dt><dd><div id="sds.TF.1.10"><p class="no_margin">Rare whole-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#sds.REF.costa.2007.96">Costa et al 2007</a>], extended conversions of exon 2 and flanking introns, or <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> rearrangements involving exon 2 have been observed.</p></div></dd><dt>11. </dt><dd><div id="sds.TF.1.11"><p class="no_margin"><a class="bk_pop" href="#sds.REF.carapito.2017.4090">Carapito et al [2017]</a></p></div></dd><dt>12. </dt><dd><div id="sds.TF.1.12"><p class="no_margin">A limited number (&#x0003c;10%) of persons with clear clinical indications of SDS do not appear to have pathogenic variants in any of the known genes, suggesting that pathogenic variants in another <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) may also be causative.</p></div></dd></dl></div></div></div></div></div></div><div id="sds.Clinical_Characteristics"><h2 id="_sds_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sds.Clinical_Description"><h3>Clinical Description</h3><p>The clinical spectrum of Shwachman-Diamond syndrome (SDS) is broad and varies among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, including sibs [<a class="bk_pop" href="#sds.REF.ginzberg.1999.81">Ginzberg et al 1999</a>]. Earlier studies suggested that gastrointestinal and hematologic findings were observed in all affected individuals [<a class="bk_pop" href="#sds.REF.cipolli.1999.265">Cipolli et al 1999</a>, <a class="bk_pop" href="#sds.REF.ginzberg.1999.81">Ginzberg et al 1999</a>]; with wider use of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, however, this belief has been challenged (see <a href="#sds.Diagnosis">Diagnosis</a>) [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>].</p><p><b>Presentation.</b> Neonates generally do not show manifestations of SDS; however, early presentations have included acute life-threatening infections, severe bone marrow failure, aplastic anemia [<a class="bk_pop" href="#sds.REF.kuijpers.2005.356">Kuijpers et al 2005</a>], asphyxiating thoracic dystrophy caused by rib cage restriction, and severe spondylometaphyseal dysplasia [<a class="bk_pop" href="#sds.REF.nishimura.2007.e73">Nishimura et al 2007</a>].</p><p>More commonly, SDS presents in infancy with failure to thrive and poor growth secondary to exocrine pancreatic dysfunction.</p><p>It should be noted, however, that the presentation of SDS varies greatly, with nearly half of individuals in the North American SDS Registry presenting without classical neutropenia and steatorrhea [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>].</p><p><b>Exocrine pancreatic dysfunction</b> resulting from severe depletion of pancreatic acinar cells is a classic feature of SDS, with the majority of dysfunction identified within the first year of life, often in the first six months. Manifestations vary widely from asymptomatic to severe dysfunction with significant malabsorption of nutrients, steatorrhea, and failure to thrive.</p><p>For unclear reasons, in many individuals manifestations resolve with age, with as many as 50% being able to discontinue pancreatic enzyme supplementation with normal fat absorption by age four years even when enzyme secretion remains deficient [<a class="bk_pop" href="#sds.REF.mack.1996.1593">Mack et al 1996</a>].</p><p>A general acinar defect has also been identified, with increased parotid acinar dysfunction in persons with SDS compared to controls [<a class="bk_pop" href="#sds.REF.stormon.2010.8">Stormon et al 2010</a>]. In a study of histologic changes in gastrointestinal mucosal biopsies of symptomatic individuals with SDS, <a class="bk_pop" href="#sds.REF.shah.2010.592">Shah et al [2010]</a> identified duodenal inflammation in more than 50%, suggesting a possible enteropathic component to their disease. This enteropathy may contribute to vitamin deficiencies observed in some individuals with SDS despite nutritional supplementation and enzymatic replacement [<a class="bk_pop" href="#sds.REF.pichler.2015.590">Pichler et al 2015</a>].</p><p>Pancreatic histopathology reveals few acinar cells and extensive fatty infiltration. Pancreatic imaging studies with ultrasonography or CT may reveal small size for age. In a series of individuals with SDS in whom <i>SBDS</i> pathogenic variants had been identified, MRI revealed fatty infiltration with retained ductal and islet components [<a class="bk_pop" href="#sds.REF.toiviainensalo.2008b.434">Toiviainen-Salo et al 2008b</a>]. Normal imaging studies do not rule out the diagnosis of SDS as these abnormal findings may emerge over time [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>].</p><p><b>Hematologic abnormalities.</b> Neutropenia and impaired neutrophil chemotaxis are likely the most critical contributors to recurrent infections seen in young children [<a class="bk_pop" href="#sds.REF.dror.2002.701">Dror &#x00026; Freedman 2002</a>, <a class="bk_pop" href="#sds.REF.stepanovic.2004.158">Stepanovic et al 2004</a>, <a class="bk_pop" href="#sds.REF.kuijpers.2005.356">Kuijpers et al 2005</a>]. Despite impaired neutrophil chemotaxis, individuals with SDS maintain the ability to form empyema and abscess, in contrast to other disorders of neutrophil chemotaxis [<a class="bk_pop" href="#sds.REF.aggett.1979.391">Aggett et al 1979</a>, <a class="bk_pop" href="#sds.REF.rothbaum.1982.800">Rothbaum et al 1982</a>]. Acute and deep-tissue infections can be life threatening, particularly in young children [<a class="bk_pop" href="#sds.REF.cipolli.2001.543">Cipolli 2001</a>, <a class="bk_pop" href="#sds.REF.grinspan.2005.179">Grinspan &#x00026; Pikora 2005</a>]. Persistent or intermittent neutropenia is recognized first in almost all (88%-100%) <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, often before the diagnosis of SDS is made [<a class="bk_pop" href="#sds.REF.ginzberg.1999.81">Ginzberg et al 1999</a>].</p><p>Although anemia and thrombocytopenia are also seen in the majority of individuals with SDS, these findings may be intermittent or clinically asymptomatic. Severe aplastic anemia with pancytopenia occurs in a subset of individuals. The French Severe Chronic Neutropenia Registry found that 41 (40%) of 102 individuals with SDS demonstrated significant hematologic manifestations, including those with intermittent severe cytopenias and 21 with persistent severe cytopenias (9 classified as malignant, 9 as nonmalignant, and 3 progressing from nonmalignant to malignant) [<a class="bk_pop" href="#sds.REF.donadieu.2012.1312">Donadieu et al 2012</a>].</p><p>The risk for myelodysplasia (MDS) or progression to leukemia &#x02013; typically acute myelogeneous leukemia (AML) &#x02013; is significant in individuals with SDS; however, data remain limited with specific reports varying by definition of MDS and cohort age.</p><ul><li class="half_rhythm"><div>One 25-year survey revealed that seven of 21 individuals with SDS developed myelodysplastic syndrome; five of these seven developed AML [<a class="bk_pop" href="#sds.REF.smith.1996.279">Smith et al 1996</a>].</div></li><li class="half_rhythm"><div>In 55 individuals with SDS in the French registry, rates of transformation to MDS/AML were 18.8% and 36.1% at 20 years and 30 years, respectively [<a class="bk_pop" href="#sds.REF.donadieu.2012.1312">Donadieu et al 2012</a>].</div></li><li class="half_rhythm"><div>The Severe Congenital Neutropenia International Registry (SCNIR) reported an overall incidence of 8.1% of MDS/AML in 37 individuals with SDS over a ten-year period, representing a 1% per year rate of progression to MDS or AML [<a class="bk_pop" href="#sds.REF.dale.2006.220">Dale et al 2006</a>, <a class="bk_pop" href="#sds.REF.rosenberg.2006.4628">Rosenberg et al 2006</a>].</div></li><li class="half_rhythm"><div>A cumulative transformation rate of 18% was reported in 34 individuals with SDS by the Canadian Inherited Bone Marrow Failure Study (CIBMFS) [<a class="bk_pop" href="#sds.REF.hashmi.2011.448">Hashmi et al 2011</a>].</div></li></ul><p>Of note, the above findings contrast with other reports from the Israeli (3 individuals) [<a class="bk_pop" href="#sds.REF.tamary.2010.1300">Tamary et al 2010</a>] and NIH (17 individuals) [<a class="bk_pop" href="#sds.REF.alter.2010.179">Alter et al 2010</a>] registries in which no one developed MDS/AML. Conclusions remain difficult given the small sample sizes; however, these differences may be attributable to cohort age [<a class="bk_pop" href="#sds.REF.myers.2013a.117">Myers et al 2013a</a>].</p><p>The risk for malignant transformation involving dysplasia or AML is considered to be lifelong, with AML generally associated with poor outcome [<a class="bk_pop" href="#sds.REF.donadieu.2005.787">Donadieu et al 2005</a>]. To date, reported malignancies other than AML have been rare; they include isolated case reports of bilateral breast cancer [<a class="bk_pop" href="#sds.REF.singh.2012.945">Singh et al 2012</a>], dermatofibrosarcoma [<a class="bk_pop" href="#sds.REF.sack.2011.568">Sack et al 2011</a>], pancreatic adenocarcinoma, and CNS lymphoma [<a class="bk_pop" href="#sds.REF.sharma.2014.564">Sharma et al 2014</a>].</p><p>It is well recognized that individuals with SDS may develop certain characteristic <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> clonal changes, such as del(20)(q11) and i(7)(q10), in the absence of overt MDS or AML. It has been suggested that these changes may persist and fluctuate over time without high risk of progression to MDS/AML [<a class="bk_pop" href="#sds.REF.cunningham.2002.1062">Cunningham et al 2002</a>, <a class="bk_pop" href="#sds.REF.crescenzi.2009.116">Crescenzi et al 2009</a>, <a class="bk_pop" href="#sds.REF.maserati.2009.190">Maserati et al 2009</a>]. Novel cytogenetic abnormalities in the presence or absence of classic del(20)(q11) and i(7)(q10) have been reported in a cohort of 91 Italian individuals with SDS, including unbalanced structural anomalies of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7, complex rearrangements of the del(20)(q), and unbalanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with partial trisomy 3q and partial <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 6q [<a class="bk_pop" href="#sds.REF.valli.2017.e26454">Valli et al 2017</a>].</p><p>Studies in which patient and non-patient marrow cells are co-cultured indicate problems with both the stem cell compartments and stromal microenvironment [<a class="bk_pop" href="#sds.REF.dror.1999.3048">Dror &#x00026; Freedman 1999</a>]. These findings, together with the wide range of abnormalities seen in the bone marrow, are consistent with SDS being a bone marrow failure syndrome.</p><p><b>Growth.</b> Children with adequate nutrition and pancreatic enzyme supplementation have normal growth velocity and appropriate weight for height; however, approximately 50% of children with SDS are below the third percentile for height and weight [<a class="bk_pop" href="#sds.REF.durie.2004">Durie &#x00026; Rommens 2004</a>].</p><p><b>Characteristic skeletal changes</b> appear to be present in all individuals with a molecularly confirmed diagnosis [<a class="bk_pop" href="#sds.REF.m_kitie.2004.101">M&#x000e4;kitie et al 2004</a>]; however, skeletal manifestations vary among individuals and over time. In some individuals the skeletal findings may be subclinical.</p><p>Cross-sectional and longitudinal data from the study of <a class="bk_pop" href="#sds.REF.m_kitie.2004.101">M&#x000e4;kitie et al [2004]</a> revealed the following:</p><ul><li class="half_rhythm"><div>Delayed appearance of secondary ossification centers, causing bone age to appear to be delayed</div></li><li class="half_rhythm"><div>Variable widening and irregularity of the metaphyses in early childhood (i.e., metaphyseal chondrodysplasia), followed by progressive thickening and irregularity of the growth plates</div></li><li class="half_rhythm"><div>Generalized osteopenia</div></li></ul><p>Of note, the epiphyseal maturation defects tended to normalize with age and the metaphyseal changes tended to progress (worsen) with age [<a class="bk_pop" href="#sds.REF.m_kitie.2004.101">M&#x000e4;kitie et al 2004</a>].</p><p>Further skeletal findings can include rib and joint abnormalities, the latter of which can result from asymmetric growth and can be sufficiently severe to warrant surgical intervention.</p><p>Additionally, low-turnover osteoporosis has been reported as a feature of SDS. <a class="bk_pop" href="#sds.REF.toiviainensalo.2007.965">Toiviainen-Salo et al [2007]</a> reported bone abnormalities in ten of 11 individuals with genetically confirmed SDS including reduced bone mineral density by Z-scores. Vertebral compression fractures were reported in three. Vitamin D and K deficiencies, both detrimental to bone health, were each identified in six individuals. It is important to ensure accurate measurement of bone mineral density, as adults with SDS have short stature and may have an incorrectly reported low bone mineral density due to low height Z-score [<a class="bk_pop" href="#sds.REF.shankar.2017.458">Shankar et al 2017</a>].</p><p><b>Hepatomegaly</b> and liver dysfunction with elevated serum aminotransferase concentration can be observed in young children but tend to resolve by age five years [<a class="bk_pop" href="#sds.REF.toiviainensalo.2007.965">Toiviainen-Salo et al 2007</a>]. Elevated bile acids were reported in one Finnish study in seven of 12 individuals with SDS, three of whom had persistent or intermittent elevation over time, raising concern for ongoing cholestasis [<a class="bk_pop" href="#sds.REF.toiviainensalo.2009.807">Toiviainen-Salo et al 2009</a>]. Mild histologic changes may also be evident in liver biopsies, and although they do not appear to be progressive, it has been noted that liver complications have occurred in older individuals following bone marrow transplantation [<a class="bk_pop" href="#sds.REF.ritchie.2002.931">Ritchie et al 2002</a>].</p><p><b>Cognitive/psychological.</b> Individuals with SDS have also been recognized to have cognitive and/or behavioral impairment as well as structural brain changes [<a class="bk_pop" href="#sds.REF.kent.1990.1349">Kent et al 1990</a>, <a class="bk_pop" href="#sds.REF.cipolli.1999.265">Cipolli et al 1999</a>, <a class="bk_pop" href="#sds.REF.ginzberg.1999.81">Ginzberg et al 1999</a>, <a class="bk_pop" href="#sds.REF.toiviainensalo.2008a.1558">Toiviainen-Salo et al 2008a</a>, <a class="bk_pop" href="#sds.REF.perobelli.2012.567">Perobelli et al 2012</a>, <a class="bk_pop" href="#sds.REF.booij.2013.102">Booij et al 2013</a>].</p><p><a class="bk_pop" href="#sds.REF.kerr.2010.433">Kerr et al [2010]</a> compared the neuropsychological function of 32 children with SDS with age- and gender-matched children with cystic fibrosis and sib controls. On a number of measures, those with SDS displayed a far wider range of abilities than controls, from severely impaired to superior. Approximately 20% of children with SDS demonstrated intellectual disability in at least one area, with perceptual reasoning being most affected. They were also far more likely than the general population to have the diagnosis of pervasive developmental disorder (6% vs 0.6%). Attention deficits were also more common in children with SDS and in their unaffected sibs than in children with cystic fibrosis.</p><p><b>Other possible findings</b></p><ul><li class="half_rhythm"><div>Ichthyosis and eczematous lesions</div></li><li class="half_rhythm"><div>Oral disease including delayed dental development, increased dental caries in both primary and permanent teeth, and recurrent oral ulcerations [<a class="bk_pop" href="#sds.REF.ho.2007.52">Ho et al 2007</a>]</div></li><li class="half_rhythm"><div>Endocrine dysfunction including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypopituitarism [<a class="bk_pop" href="#sds.REF.jivani.2016.1325">Jivani et al 2016</a>], diabetes, and growth hormone deficiency [<a class="bk_pop" href="#sds.REF.myers.2013b.1235">Myers et al 2013b</a>]</div></li><li class="half_rhythm"><div>Immune dysfunction [<a class="bk_pop" href="#sds.REF.dror.2001.712">Dror et al 2001</a>]</div></li><li class="half_rhythm"><div>Congenital anomalies including: cardiac, gastrointestinal, neurologic, urinary tract/kidney, or eye and ear anomalies [<a class="bk_pop" href="#sds.REF.myers.2014.866">Myers et al 2014</a>]</div></li></ul></div><div id="sds.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed for any of the genes associated with SDS.</p></div><div id="sds.Nomenclature"><h3>Nomenclature</h3><p>Previously used terms for SDS:</p><ul><li class="half_rhythm"><div>Shwachman's syndrome</div></li><li class="half_rhythm"><div>Congenital lipomatosis of the pancreas</div></li><li class="half_rhythm"><div>Shwachman-Bodian syndrome</div></li></ul></div><div id="sds.Prevalence"><h3>Prevalence</h3><p>It has been estimated that SDS occurs in one of 77,000 births based on the observation that it is approximately 1/20th as frequent as cystic fibrosis in North America [<a class="bk_pop" href="#sds.REF.goobie.2001.1048">Goobie et al 2001</a>].</p><p>SDS occurs in diverse populations including those with European, Indian, aboriginal (North America), Chinese, Japanese, and African ancestry.</p></div></div><div id="sds.Genetically_Related_Allelic_Disorder"><h2 id="_sds_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>DNAJC21</i>, <i>EFL1</i>, or <i>SBDS</i>.</p><p>Heterozygous <i>SRP54</i> pathogenic variants may also be associated with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia [<a class="bk_pop" href="#sds.REF.bellann_chantelot.2018.1318">Bellann&#x000e9;-Chantelot et al 2018</a>].</p></div><div id="sds.Differential_Diagnosis"><h2 id="_sds_Differential_Diagnosis_">Differential Diagnosis</h2><p>Features of Shwachman-Diamond syndrome (SDS) (e.g., poor growth and transient neutropenia) may have multiple causes in young children (see <a class="figpopup" href="/books/NBK1756/table/sds.T.disorders_to_consider_in_the_diffe/?report=objectonly" target="object" rid-figpopup="figsdsTdisorderstoconsiderinthediffe" rid-ob="figobsdsTdisorderstoconsiderinthediffe">Table 2</a>).</p><div id="sds.T.disorders_to_consider_in_the_diffe" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Shwachman-Diamond Syndrome (SDS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.disorders_to_consider_in_the_diffe/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.disorders_to_consider_in_the_diffe_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder /<br />Clinical<br />Circumstance</th><th id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Disorder / Comments</th></tr><tr><th headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/SDS</th><th headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SDS</th></tr></thead><tbody><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cf/">Cystic fibrosis</a> (CF)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CFTR</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CF often presents w/both upper-respiratory infections &#x00026; exocrine pancreatic dysfunction.</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In CF:
<ul><li class="half_rhythm"><div>Elevated sweat chloride values</div></li><li class="half_rhythm"><div>No primary bone marrow failure</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Johanson-Blizzard syndrome (JBS)<br />(OMIM <a href="https://omim.org/entry/243800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243800</a>)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UBR1</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exocrine pancreatic dysfunction</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In JBS:
<ul><li class="half_rhythm"><div>Anomalies &#x00026; severe developmental delays</div></li><li class="half_rhythm"><div>No hematologic abnormalities</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe malnutrition</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Failure to thrive</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In severe malnutrition:
<ul><li class="half_rhythm"><div>Clinical picture consistent w/inadequate caloric/protein intake</div></li><li class="half_rhythm"><div>No underlying <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> diagnosis</div></li><li class="half_rhythm"><div>No exocrine pancreatic dysfunction</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pearson marrow-pancreas syndrome (PMPS)<br />(OMIM <a href="https://omim.org/entry/557000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">557000</a>)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mt</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exocrine pancreatic dysfunction &#x00026; bone marrow dysfunction</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In PMPS:
<ul><li class="half_rhythm"><div>Normal cellularity in bone marrow, w/distinct cytoplasmic vacuolization in myeloid precursors</div></li><li class="half_rhythm"><div>mtDNA contiguous-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPINK1</i>-related severe infantile <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> exocrine pancreatic insufficiency&#x000a0;<sup>2</sup></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPINK1</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exocrine pancreatic dysfunction</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No bone marrow failure or neutropenia</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/diamond-b/">Diamond-Blackfan anemia</a> (DBA)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18 genes</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />XL</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone marrow failure</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In DBA:
<ul><li class="half_rhythm"><div>Progressive macrocytic anemia w/reticulocytopenia</div></li><li class="half_rhythm"><div>Normal cellularity bone marrow w/markedly decreased or absent erythroid precursors</div></li><li class="half_rhythm"><div>No primary exocrine pancreatic dysfunction</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fa/">Fanconi anemia</a> (FA)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21 genes</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD<br />XL</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone marrow failure</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In FA:
<ul><li class="half_rhythm"><div>Progressive pancytopenia w/positive <a class="def" href="/books/n/gene/glossary/def-item/chromosome-breakage-studies/">chromosome breakage studies</a></div></li><li class="half_rhythm"><div>Variable cellularity of the bone marrow w/decreased precursors</div></li><li class="half_rhythm"><div>No primary exocrine pancreatic dysfunction</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dkc/">Dyskeratosis congenita</a> (DC)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 genes</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AD<br />AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone marrow failure</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In DC:
<ul><li class="half_rhythm"><div>Abnormally shortened telomere length</div></li><li class="half_rhythm"><div>Variable cellularity of bone marrow w/reduced precursors</div></li><li class="half_rhythm"><div>No primary exocrine pancreatic dysfunction</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Medications or infections</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neutropenia</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neutropenia caused by medications or infections is transient.</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kostmann <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia<br />(OMIM <a href="http://omim.org/entry/610738" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610738</a>)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HAX1</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neutropenia</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Kostmann <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia:
<ul><li class="half_rhythm"><div>Severe neutropenia</div></li><li class="half_rhythm"><div>On hematologic testing: early myeloid arrest at promyelocyte/ myelocyte stage, w/atypical nuclei &#x00026; cytoplasmic vacuolization</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cyclic-n/"><i>ELANE</i>-related neutropenia</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELANE</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neutropenia</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In <i>ELANE</i>-related neutropenia:
<ul><li class="half_rhythm"><div>Severe neutropenia w/mutation of <i>ELANE</i></div></li><li class="half_rhythm"><div>On hematologic testing: <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> neutropenia</div></li></ul>
</td></tr><tr><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chh/">Cartilage-hair hypoplasia</a> (CHH)</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RMRP</i></td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal dysplasia</td><td headers="hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sds.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In CHH:
<ul><li class="half_rhythm"><div>Short at birth, w/abnormal long-bone growth. Increased incidence of scoliosis, abnormal pubertal growth spurt, &#x00026; global dysfunction of skeletal growth (axial &#x00026; appendicular)</div></li><li class="half_rhythm"><div>Gastrointestinal features are secondary to complications of infection (rather than to exocrine pancreatic insufficiency as in SDS).</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> (ordered by relative frequency if multiple MOIs); mt = mitochondrial; NA = not applicable; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="sds.TF.2.1"><p class="no_margin">Pearson marrow-pancreas syndrome is caused by mtDNA contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications (OMIM <a href="http://omim.org/entry/557000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">557000</a>).</p></div></dd><dt>2. </dt><dd><div id="sds.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#sds.REF.venet.2017.1660">Venet et al [2017]</a></p></div></dd><dt>3. </dt><dd><div id="sds.TF.2.3"><p class="no_margin"><i>ELANE</i>-related neutropenia includes cyclic neutropenia and severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia.</p></div></dd></dl></div></div></div></div><div id="sds.Management"><h2 id="_sds_Management_">Management</h2><div id="sds.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual following the initial diagnosis of Shwachman-Diamond syndrome (SDS), current consensus practice typically recommends the following evaluations to assess the status of the pancreas, liver, bone marrow, and skeleton [<a class="bk_pop" href="#sds.REF.dror.2011.40">Dror et al 2011</a>].</p><ul><li class="half_rhythm"><div>Assessment of growth: height, weight in relation to age</div></li><li class="half_rhythm"><div>Assessment of nutritional status to determine if supplementation with pancreatic enzymes is necessary and/or effective:</div><ul><li class="half_rhythm"><div>Measurement of fat-soluble vitamins (vitamin A, 25-OH-vitamin D, and vitamin E) or their related metabolites</div></li><li class="half_rhythm"><div>Measurement of prothrombin time (to detect vitamin K deficiency)</div></li></ul></li><li class="half_rhythm"><div>Assessment of serum concentration of the digestive enzyme cationic trypsinogen and, if sufficiency is observed, subsequent confirmation with a 72-hour fecal fat balance study (with discontinuation of enzyme supplementation for at least a 24-hour period)</div></li><li class="half_rhythm"><div>Pancreatic imaging by ultrasound</div></li><li class="half_rhythm"><div>Complete blood count with white cell differential and platelet count</div></li><li class="half_rhythm"><div>Measurement of iron, folate, and B<sub>12</sub></div></li><li class="half_rhythm"><div>Bone marrow examination with biopsy and <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> studies at initial assessment</div></li><li class="half_rhythm"><div>Immunoglobulins and lymphocyte subpopulations</div></li><li class="half_rhythm"><div>Skeletal survey with radiographs of at least the hips and lower limbs</div></li><li class="half_rhythm"><div>Bone densitometry as clinically indicated</div></li><li class="half_rhythm"><div>Assessment of serum aminotransferase levels</div></li><li class="half_rhythm"><div>Assessment of developmental milestones (including pubertal development) with neuropsychological evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sds.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>A multidisciplinary team including specialists from the following fields is recommended: hematology, gastroenterology, clinical genetics, orthopedics, endocrinology, immunology, dentistry, child development, psychology, and social work as needed [<a class="bk_pop" href="#sds.REF.dror.2002.701">Dror &#x00026; Freedman 2002</a>, <a class="bk_pop" href="#sds.REF.rothbaum.2002.266">Rothbaum et al 2002</a>, <a class="bk_pop" href="#sds.REF.durie.2004">Durie &#x00026; Rommens 2004</a>, <a class="bk_pop" href="#sds.REF.dror.2011.40">Dror et al 2011</a>, <a class="bk_pop" href="#sds.REF.myers.2013a.117">Myers et al 2013a</a>].</p><p><b>Exocrine pancreatic insufficiency</b> can be treated with the same oral pancreatic enzymes commonly used in treatment of <a href="/books/n/gene/cf/">cystic fibrosis</a>; dose should be based on results of routine assessment of pancreatic function and nutritional status. Steatorrhea often resolves in early childhood, but pancreatic enzyme levels can remain low; routine monitoring (see <a href="#sds.Surveillance">Surveillance</a>) is recommended.</p><p>Supplementation with fat-soluble vitamins (A, D, E, and K) is recommended.</p><p><b>Hematologic abnormalities.</b> Blood and/or platelet transfusions may be considered for anemia and bi- or trilineage cytopenia.</p><p>If recurrent infections are severe and absolute neutrophil counts are persistently &#x02264;500/mm<sup>3</sup>, treatment with prophylactic antibiotics and granulocyte-colony stimulation factor (G-CSF) can be considered with caution (see <a href="#sds.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>).</p><p>Hematopoietic stem cell transplantation (HSCT) should be considered for treatment of severe pancytopenia, bone marrow transformation to myelodysplastic syndrome, or acute myelogeneous leukemia (AML). Chemotherapy can be utilized as a bridge to HSCT in individuals with SDS and AML; however, sustained complete remission is problematic and prompt continuation to HSCT remains imperative. Although earlier reports indicate that survival is fair, cautious myeloablation and newer reduced-intensity regimens have demonstrated improved outcomes in small cohorts [<a class="bk_pop" href="#sds.REF.cesaro.2005.231">Cesaro et al 2005</a>, <a class="bk_pop" href="#sds.REF.vibhakar.2005.855">Vibhakar et al 2005</a>, <a class="bk_pop" href="#sds.REF.sauer.2007.143">Sauer et al 2007</a>, <a class="bk_pop" href="#sds.REF.bhatla.2008.159">Bhatla et al 2008</a>].</p><p>Note: Bone marrow abnormalities are not treated unless severe aplasia, myelodysplastic changes, or leukemic transformation are present.</p><p><b>Skeletal abnormalities.</b> Skeletal manifestations of SDS may range from clinically asymptomatic to severe, and can evolve or progress over time. Severe manifestations such as asphyxiating thoracic dystrophy due to rib cage restriction will require subspecialty care including pediatric pulmonary and orthopedic specialists. Other rib and joint abnormalities may require surgical intervention if severe, and consultation with an orthopedic surgeon familiar with SDS may be beneficial for those with skeletal dysplasia.</p><p>Evaluate for treatment for low bone density if indicated by bone densitometry*.</p><p><b>Growth.</b> Children with poor growth and delayed puberty benefit from ongoing consultation with an endocrinologist, who may also consult with orthopedists regarding possible surgical management of asymmetric growth and joint deformities.</p><p><b>Other.</b> Cognitive, learning, and behavioral complications can be features of SDS, and remedial interventions are considered beneficial.</p></div><div id="sds.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Frequent dental visits to monitor tooth development and oral health are recommended to reduce the incidence of mouth ulcers and gingivitis. Home care should include aggressive dental hygiene with topical fluoride treatments to help prevent dental decay.</p><p>Prophylactic antibiotics and G-CSF may be especially helpful when interventions such as complex dental procedures or orthopedic surgery are being considered (see <a href="#sds.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>).</p></div><div id="sds.Surveillance"><h3>Surveillance</h3><p>The following are recommended given the intermittent nature of some features of SDS and the evolution of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> over time [<a class="bk_pop" href="#sds.REF.rothbaum.2002.266">Rothbaum et al 2002</a>, <a class="bk_pop" href="#sds.REF.dror.2011.40">Dror et al 2011</a>, <a class="bk_pop" href="#sds.REF.myers.2013a.117">Myers et al 2013a</a>]:</p><ul><li class="half_rhythm"><div>Complete blood counts with white blood cell differential and platelet counts at least every three to six months, or more frequently if peripheral blood counts are changing or infections are recurrent and debilitating</div></li><li class="half_rhythm"><div>Bone marrow examinations every one to three years following the baseline examination, and more frequently if changes in bone marrow function or cellularity are observed</div></li><li class="half_rhythm"><div>Assessment of nutritional status every six months and measurement of serum concentration of vitamins to evaluate effectiveness of or need for pancreatic enzyme therapy</div></li><li class="half_rhythm"><div>Monitoring for orthopedic complications with x-rays of hips and knees during the most rapid growth stages</div></li><li class="half_rhythm"><div>Bone densitometry before puberty, during puberty, and thereafter based on individual findings. Results must be interpreted in the context of stature and pubertal status.</div></li><li class="half_rhythm"><div>Developmental assessment every six months from birth to age six years and growth every six months</div></li><li class="half_rhythm"><div>Neuropsychological screening in children age 6-8 years, 11-13 years, and 15-17 years</div></li></ul></div><div id="sds.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Prolonged use of cytokine and hematopoietic growth factors such as G-CSF is cautioned against in view of their potential contribution to leukemic transformation [<a class="bk_pop" href="#sds.REF.rosenberg.2006.4628">Rosenberg et al 2006</a>].</p><p>Some drugs (e.g., cyclophosphamide and busulfan) used in standard HSCT preparative regimens may not be suitable because of possible cardiac toxicity [<a class="bk_pop" href="#sds.REF.mitsui.2004.189">Mitsui et al 2004</a>, <a class="bk_pop" href="#sds.REF.cesaro.2005.231">Cesaro et al 2005</a>, <a class="bk_pop" href="#sds.REF.vibhakar.2005.855">Vibhakar et al 2005</a>, <a class="bk_pop" href="#sds.REF.sauer.2007.143">Sauer et al 2007</a>].</p></div><div id="sds.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate as early as possible the older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify those who will benefit from treatment and preventive measures. This can also potentially prevent asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs from being used as bone marrow transplant donors.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Testing for exocrine pancreatic dysfunction and evidence of bone marrow failure with single- or multilineage cytopenia if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#sds.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sds.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For pregnancies in women with SDS, high-risk pregnancy care including consultation with a hematologist is recommended [<a class="bk_pop" href="#sds.REF.alter.1999.49">Alter et al 1999</a>]. Women with SDS are at increased risk for recurrent miscarriages, but the rates of elective abortion, live birth, and spontaneous miscarriage are comparable to the general population [<a class="bk_pop" href="#sds.REF.giri.2018">Giri et al 2018</a>].</p></div><div id="sds.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sds.Genetic_Counseling"><h2 id="_sds_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sds.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Shwachman-Diamond syndrome (SDS) caused by pathogenic variants in <i>EFL1</i>, <i>DNAJC21</i>, or <i>SBDS</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. SDS caused by pathogenic variants in <i>SRP54</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sds.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are usually heterozygotes (i.e., carriers of one SDS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Occasionally, only one parent is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> as the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child has one inherited and one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Approximately 10% of <i>SBDS</i> pathogenic variants are <i>de novo</i> [<a class="bk_pop" href="#sds.REF.steele.2014">Steele et al 2014</a>]. The rate of <i>de novo</i> pathogenic variants for the other genes is not known.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. See <a href="#sds.Carrier_Heterozygote_Detection">Carrier (Heterozygote) Detection</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>When both parents are known to be carriers, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has, at conception, a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>When the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has one inherited and one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has, at conception, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> and a 50% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. See <a href="#sds.Carrier_Heterozygote_Detection">Carrier (Heterozygote) Detection</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> SDS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes associated with SDS.</div></li><li class="half_rhythm"><div>In the rare event that the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, the offspring are at a 50% risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and a 50% risk of being carriers.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. (If one variant is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, this risk only applies to the sibs of the carrier parent.)</p></div><div id="sds.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the pathogenic variants in the family.</p><p>Note that carriers are clinically asymptomatic:</p><ul><li class="half_rhythm"><div>Although it has been suggested that carriers (heterozygotes) with one pathogenic <i>SBDS</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may be at higher-than-average risk for aplastic anemia [<a class="bk_pop" href="#sds.REF.calado.2007.1141">Calado et al 2007</a>], aplastic anemia has not been observed among <i>SBDS</i> heterozygotes (i.e., carriers) in more than 200 families with SDS [J Rommens, unpublished; North American SDS Registry; Author, unpublished].</div></li><li class="half_rhythm"><div>Sequence analysis of DNA obtained from bone marrow samples from 77 persons with acute myelogeneous leukemia (AML) did not reveal any <i>SBDS</i> pathogenic variants [<a class="bk_pop" href="#sds.REF.majeed.2005.920">Majeed et al 2005</a>]. Subsequently, in a larger cohort of 160 children with AML, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SBDS</i> pathogenic variants were present at similar frequencies to those of healthy blood donor controls, and no <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants were identified [<a class="bk_pop" href="#sds.REF.aalbers.2013.559">Aalbers et al 2013</a>].</div></li></ul></div><div id="sds.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, most individuals diagnosed with <i>SRP54</i>-related SDS have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>SRP54</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent is known to have the <i>SRP54</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>SRP54</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#sds.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>SRP54</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for <i>SRP54</i>-related SDS because of the theoretic possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>SRP54</i>-related SDS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="sds.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#sds.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sds.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the SDS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="sds.Resources"><h2 id="_sds_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Associazione Italiana Sindrome di Shwachman</b></div><div>Via S. Anna 15/A</div><div>Post Office nr. 10025625</div><div>Montecassiano 62010</div><div>Italy</div><div><b>Email:</b> aiss@iol.it</div><div><a href="http://users.libero.it/aiss/index_ing.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.shwachman.it</a></div></li><li class="half_rhythm"><div><b>Shwachman-Diamond Syndrome Canada</b></div><div>2152 Gatley Road</div><div>Mississauga Ontario L5H 3L9</div><div>Canada</div><div><b>Phone:</b> 866-462-8907 (toll-free)</div><div><b>Email:</b> info@shwachman.org</div><div><a href="http://sdscanada.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://sdscanada.ca/</a></div></li><li class="half_rhythm"><div><b>Shwachman-Diamond Syndrome Foundation</b></div><div>127 Western Avenue</div><div>Sherborn MA 01770</div><div><b>Phone:</b> 888-825-7373 (toll-free)</div><div><b>Fax:</b> 888-825-7373 (toll-free)</div><div><b>Email:</b> info@shwachman-diamond.org</div><div><a href="http://www.shwachman-diamond.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.shwachman-diamond.org</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>National Cancer Institute Inherited Bone Marrow Failure Syndromes (IBMFS) Cohort Registry</b></div><div><b>Phone:</b> 800-518-8474</div><div><b>Email:</b> NCI.IBMFS@westat.com</div><div><a href="https://www.marrowfailure.cancer.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.marrowfailure.cancer.gov</a></div></li><li class="half_rhythm"><div><b>Shwachman-Diamond Syndrome Registry</b></div><div><a href="http://shwachman-diamond.org/sds-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.shwachman-diamond.org/sds-registry</a></div></li></ul></div><div id="sds.Molecular_Genetics"><h2 id="_sds_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sds.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Shwachman-Diamond Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/134218" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DNAJC21</i></a></td><td headers="hd_b_sds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=134218" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5F1R6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DnaJ homolog subfamily C member 21</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_sds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DNAJC21" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNAJC21</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DNAJC21[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNAJC21</a></td></tr><tr><td headers="hd_b_sds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79631" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EFL1</i></a></td><td headers="hd_b_sds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79631" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q25<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z2Z2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Elongation factor-like GTPase 1</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_sds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EFL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EFL1</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EFL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EFL1</a></td></tr><tr><td headers="hd_b_sds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/51119" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SBDS</i></a></td><td headers="hd_b_sds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=51119" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y3A5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribosome maturation protein SBDS</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SBDS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SBDS database</a><br /><a href="http://structure.bmc.lu.se/idbase/SBDSbase/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SBDSbase: Mutation registry for Shwachman-Diamond syndrome</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SBDS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SBDS</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SBDS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SBDS</a></td></tr><tr><td headers="hd_b_sds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6729" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SRP54</i></a></td><td headers="hd_b_sds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6729" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P61011" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Signal recognition particle 54 kDa protein</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_sds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SRP54" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SRP54</a></td><td headers="hd_b_sds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SRP54[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SRP54</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sds.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sds.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Shwachman-Diamond Syndrome (<a href="/omim/260400,604857,607444,617048,617941" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/260400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">260400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SHWACHMAN-DIAMOND SYNDROME 1; SDS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604857" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604857</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SIGNAL RECOGNITION PARTICLE, 54-KD; SRP54</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607444" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607444</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SBDS GENE; SBDS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617048" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617048</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 21; DNAJC21</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617941" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617941</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SHWACHMAN-DIAMOND SYNDROME 2; SDS2</td></tr></tbody></table></div></div><div id="sds.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Schwachman-Diamond syndrome (SDS) is caused by pathogenic variants in the <i>DNAJC21</i>, <i>EFL1</i>, <i>SBDS</i>, or <i>SRP54</i>. The majority of cases are associated with <i>SBDS</i>, which encodes SBDS, a protein that plays a central role in ribosome biogenesis. Interestingly, the genes more recently found to be associated with SDS &#x02013; <i>DNAJC21</i>, <i>EFL1</i>, and <i>SRP54</i> &#x02013; all play a role in ribosome biogenesis and function.</p><div id="sds.DNAJC21"><h4><i>DNAJC21</i></h4><p><b>Gene structure.</b>
<i>DNAJC21</i> is ubiquitously expressed. It is located on the short arm of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 5 (5p.13.2). It contains at least 12 exons and spans more than 25.6 kb. See <a href="/books/NBK1756/#sds.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Sequence analysis of <i>DNAJC21</i> (involved in ribosomal biogenesis) revealed the pathogenic variants p.Lys34Glu and p.Gln174Ter [<a class="bk_pop" href="#sds.REF.dhanraj.2017.1557">Dhanraj et al 2017</a>].</p><div id="sds.T.dnajc21_pathogenic_variants_discus" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>DNAJC21</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.dnajc21_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.dnajc21_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.520C&#x0003e;T</td><td headers="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln174Ter</td><td headers="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001012339.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001012339<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_001012339.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001012339<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.100A&#x0003e;G</td><td headers="hd_h_sds.T.dnajc21_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys34Glu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>DNAJC21</i> encodes a protein with a common isoform of 531 amino acids. Studies of the yeast homolog support the role for <i>DNAJC21</i> in ribosome biogenesis.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Deletion of the yeast <i>DNAJC21</i> homolog <i>Jjj1</i> leads to reduced levels of mature ribosomes and dysfunctional 60S ribosome subunit biogenesis.</p></div><div id="sds.EFL1"><h4><i>EFL1</i></h4><p><b>Gene structure.</b>
<i>EFL1</i> has 13 exons and is located on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 13q. See <a href="/books/NBK1756/#sds.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Homozygous pathogenic variants in <i>EFL1</i> have been associated with disease. Two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for p.Met882Lys and four affected individuals homozygous for p.Arg1095Gln have been described [<a class="bk_pop" href="#sds.REF.stepensky.2017.558">Stepensky et al 2017</a>].</p><div id="sds.T.efl1_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>EFL1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.efl1_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.efl1_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2645T&#x0003e;A</td><td headers="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met882Lys</td><td headers="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_024580.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024580<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_078856.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_078856<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3284G&#x0003e;A</td><td headers="hd_h_sds.T.efl1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1095Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>EFL1</i> is a partner for SBDS protein and is involved in the formation of mature ribosomes. <i>ELF1</i> interacts with the 60S ribosomal subunit to prevent premature association of the ribosomal subunits in the nucleus.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>EFL1</i> do not disrupt protein folding but rather prevent release of the protein from the 60S subunit, resulting in abnormal ribosomes with altered translating capabilities.</p></div><div id="sds.SBDS"><h4><i>SBDS</i></h4><p><b>Gene structure.</b>
<i>SBDS</i> has five exons and spans &#x0003c;9 kb. Notable aspects of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are its pericentromeric location on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7q and occurrence within a 305-kb segment that appears duplicated and inverted, 5.8 megabases (Mb) distally [<a class="bk_pop" href="#sds.REF.boocock.2003.97">Boocock et al 2003</a>]. For a detailed summary of gene and protein information, see <a href="/books/NBK1756/#sds.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Some of the benign variants reflect the sequence of the <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> <i>SBDSP</i>, indicating that they may have arisen by <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> events between the gene and the pseudogene.</p><p><b>Pathogenic variants.</b> The abnormalities identified in individuals with SDS lead to prematurely truncated proteins, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> aberrations, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> alterations.</p><p>At least one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in more than 90% of individuals with Shwachman-Diamond syndrome (SDS) has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 that apparently arose by <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a>, a process by which a small segment of the functional gene, <i>SBDS</i>, is replaced by a segment copied from the highly homologous nonfunctional <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> <i>SBDSP</i>. As a result, this segment of <i>SBDS</i> has sequence variants (typical of the pseudogene) that inactivate normal <i>SBDS</i> gene expression and/or translation of normal protein.</p><p>The three most common pathogenic alleles resulting from <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> and accounting for more than 76% of disease-causing alleles in more than 200 families are the following [J Rommens, unpublished]:</p><ul><li class="half_rhythm"><div>c.183_184delinsCT</div></li><li class="half_rhythm"><div>c.258+2T&#x0003e;C</div></li><li class="half_rhythm"><div>c.[183_184delinsCT; 258+2T&#x0003e;C], in which both pathogenic variants occur on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a></div></li></ul><p>Nearly 100 novel sequence variants identified in the five exons of <i>SBDS</i> are consistent with <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> alterations [<a class="bk_pop" href="#sds.REF.boocock.2003.97">Boocock et al 2003</a>, <a class="bk_pop" href="#sds.REF.nicolis.2005.410">Nicolis et al 2005</a>, <a class="bk_pop" href="#sds.REF.maserati.2006.375">Maserati et al 2006</a>, <a class="bk_pop" href="#sds.REF.taneichi.2006.60">Taneichi et al 2006</a>]. Seven have been found in multiple, apparently unrelated families (see <a class="figpopup" href="/books/NBK1756/table/sds.T.sbds_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figsdsTsbdspathogenicvariantsdiscussed" rid-ob="figobsdsTsbdspathogenicvariantsdiscussed">Table 5</a>).</p><p>Except for one reported case to date, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with rare pathogenic variants are compound heterozygotes with one of the three common <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>-derived pathogenic variants. In the one exception, an individual with a clinical diagnosis of SDS had two rare <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 and exon 4 [<a class="bk_pop" href="#sds.REF.erdos.2006.1517">Erdos et al 2006</a>].</p><div id="sds.T.sbds_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>SBDS</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.sbds_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.sbds_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.119delG</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser41AlafsTer18</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=28416939" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_016038<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=28416940" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_057122<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.183_184delinsCT&#x000a0;<sup>2</sup><br />(c.183TA&#x0003e;CT)</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys62Ter</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[183_184delinsCT; 258+2T&#x0003e;C]&#x000a0;<sup>2</sup></td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys62Ter</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.258+1G&#x0003e;C</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.258+2T&#x0003e;C&#x000a0;<sup>2</sup></td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys84TyrfsTer4</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.297_300delAAGA&#x000a0;<sup>2</sup></td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu9AspfsTer20</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.377G&#x0003e;C</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg126Thr</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.505C&#x0003e;T</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg169Cys</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.624+1G&#x0003e;C</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.652C&#x0003e;T</td><td headers="hd_h_sds.T.sbds_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg218Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="sds.TF.5.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="sds.TF.5.2"><p class="no_margin">Likely the consequence of <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> with <i>SBDSP</i></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SBDS</i> encodes a highly conserved protein of 250 amino acids that appears to occur in all animals, plants, and archaea [<a class="bk_pop" href="#sds.REF.boocock.2003.97">Boocock et al 2003</a>]. The structural analysis of an archaeal ortholog indicates that the SBDS protein contains three domains [<a class="bk_pop" href="#sds.REF.savchenko.2005.19213">Savchenko et al 2005</a>, <a class="bk_pop" href="#sds.REF.shammas.2005.19221">Shammas et al 2005</a>].</p><p>The SBDS protein is believed to play a role in RNA metabolism and ribosome biogenesis. Studies have demonstrated SBDS protein association with the large 60S ribosomal subunit, as well as association with multiple ribosomal proteins [<a class="bk_pop" href="#sds.REF.ganapathi.2007.1458">Ganapathi et al 2007</a>, <a class="bk_pop" href="#sds.REF.ball.2009.3684">Ball et al 2009</a>]. Genetic studies of the yeast homolog also support a role in 60S ribosomal subunit biogenesis and translational activation [<a class="bk_pop" href="#sds.REF.menne.2007.486">Menne et al 2007</a>]. Recent studies examining the interaction of SBDS with the GTPase elongation factor-like 1 (ELF1) [<a class="bk_pop" href="#sds.REF.finch.2011.917">Finch et al 2011</a>] endorse a model in which SBDS initiates the joining of the 40S and 60S subunits for active translation through the creation of the active 80S ribosome.</p><p>In addition to its role in ribosomal biogenesis, SBDS protein has been implicated in mitochondrial function. Reduced expression of <i>SBDS</i> decreases mitochondrial membrane potential and increases the production of reactive oxygen species, which may contribute to SDS pathophysiology [<a class="bk_pop" href="#sds.REF.henson.2013.29">Henson et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants identified in individuals with SDS led to prematurely truncated proteins, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> aberrations, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> alterations. These pathogenic variants are predicted to result in absence or loss of function of the SBDS protein. Despite the relatively common occurrence of the <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> c.183_184delinsCT (p.Lys62Ter), no homozygotes have been reported. This is consistent with the observations of a mouse model in which complete loss of both <i>Sbds</i> alleles was not compatible with life [<a class="bk_pop" href="#sds.REF.zhang.2006.6656">Zhang et al 2006</a>]. It is therefore anticipated that some residual activity of the SBDS protein is required for development to occur.</p></div><div id="sds.SRP54"><h4><i>SRP54</i></h4><p><b>Gene structure.</b>
<i>SRP54</i> is located on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 14q and contains 14 exons. See <a href="/books/NBK1756/#sds.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b>
<i>De novo</i> pathogenic variants p.Thr115Ala, p.Thr117del, and p.Gly226Glu have been described in individuals with the SDS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#sds.REF.carapito.2017.4090">Carapito et al 2017</a>].</p><div id="sds.T.srp54_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>SRP54</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1756/table/sds.T.srp54_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sds.T.srp54_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.677G&#x0003e;A</td><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly226Glu</td><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003136.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003136<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_003127.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003127<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.343A&#x0003e;G</td><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr115Ala</td></tr><tr><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.349_351delACA</td><td headers="hd_h_sds.T.srp54_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr117del</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> SRP54 is involved in protein translation. It is part of a single RNA molecule made up of six polypeptides (SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72). SRP54 plays a central role in the ribonucleoprotein complex signal pathway facilitating signal sequencing at the endoplasmic reticulum surface.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>SRP54</i> lead to both quantitative and qualitative disruption of secreted and membrane-bound protein synthesis, along with changes in cellular protein content.</p></div></div></div><div id="sds.References"><h2 id="_sds_References_">References</h2><div id="sds.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sds.REF.aalbers.2013.559">Aalbers AM, Calado RT, Young NS, Zwaan CM, Kajigaya S, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Reinhardt D, Trka J, Kuijpers TW, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM. Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia. <span><span class="ref-journal">Br J Haematol. </span>2013;<span class="ref-vol">160</span>:559–61.</span> [<a href="/pmc/articles/PMC3594451/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3594451</span></a>] [<a href="/pubmed/23189942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23189942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.aggett.1979.391">Aggett PJ, Harries JT, Harvey BA, Soothill JF. An inherited defect of neutrophil mobility in Shwachman syndrome. <span><span class="ref-journal">J Pediatr. </span>1979;<span class="ref-vol">94</span>:391–4.</span> [<a href="/pubmed/423020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 423020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.alter.2010.179">Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. <span><span class="ref-journal">Br J Haematol. </span>2010;<span class="ref-vol">150</span>:179–88.</span> [<a href="/pmc/articles/PMC3125983/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3125983</span></a>] [<a href="/pubmed/20507306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20507306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.alter.1999.49">Alter BP, Kumar M, Lockhart LL, Sprinz PG, Rowe TF. Pregnancy in bone marrow failure syndromes: Diamond-Blackfan anaemia and Shwachman-Diamond syndrome. <span><span class="ref-journal">Br J Haematol. </span>1999;<span class="ref-vol">107</span>:49–54.</span> [<a href="/pubmed/10520024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10520024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ball.2009.3684">Ball HL, Zhang B, Riches JJ, Gandhi R, Li J, Rommens JM, Myers JS. Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:3684–95.</span> [<a href="/pmc/articles/PMC2742402/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2742402</span></a>] [<a href="/pubmed/19602484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19602484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.bellann_chantelot.2018.1318">Bellann&#x000e9;-Chantelot C, Schmaltz-Panneau B, Marty C, Fenneteau O, Callebaut I, Clauin S, Docet A, Damaj GL, Leblanc T, Pellier I, Stoven C, Souquere S, Antony-Debr&#x000e9; I, Beaupain B, Aladjidi N, Barlogis V, Bauduer F, Bensaid P, Boespflug-Tanguy O, Berger C, Bertrand Y, Carausu L, Fieschi C, Galambrun C, Schmidt A, Journel H, Mazingue F, Nelken B, Quah TC, Oksenhendler E, Ouach&#x000e9;e M, Pasquet M, Saada V, Suarez F, Pierron G, Vainchenker W, Plo I, Donadieu J. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome. <span><span class="ref-journal">Blood. </span>2018;<span class="ref-vol">132</span>:1318–31.</span> [<a href="/pmc/articles/PMC6536700/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6536700</span></a>] [<a href="/pubmed/29914977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29914977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.bhatla.2008.159">Bhatla D, Davies SM, Shenoy S, Harris RE, Crockett M, Shoultz L, Smolarek T, Bleesing J, Hansen M, Jodele S, Jordan M, Filipovich AH, Mehta PA. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2008;<span class="ref-vol">42</span>:159–65.</span> [<a href="/pubmed/18500373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18500373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.boocock.2003.97">Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, Rommens JM. Mutations in SBDS are associated with Shwachman-Diamond syndrome. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:97–101.</span> [<a href="/pubmed/12496757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12496757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.booij.2013.102">Booij J, Reneman L, Alders M, Kuijpers TW. Increase in central striatal dopamine transporters in patients with Shwachman&#x02013;Diamond syndrome: Additional evidence of a brain phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:102–7.</span> [<a href="/pubmed/23239620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23239620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.calado.2007.1141">Calado RT, Graf SA, Wilkerson KL, Kajigaya S, Ancliff PJ, Dror Y, Chanock SJ, Lansdorp PM, Young NS. Mutations in the SBDS gene in acquired aplastic anemia. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>:1141–6.</span> [<a href="/pmc/articles/PMC1939897/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1939897</span></a>] [<a href="/pubmed/17478638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17478638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.carapito.2017.4090">Carapito R, Konantz M, Paillard C, Miao Z, Pichot A, Leduc MS, Yang Y, Bergstrom KL, Mahoney DH, Shardy DL, Alsaleh G, Naegely L, Kolmer A, Paul N, Hanauer A, Rolli V, Muller JS, Alghisi E, Sauteur L, Macquin C, Morlon A, Sancho CS, Amati-Bonneau P, Procaccio V, Mosca-Boidron A-L, Marle N, Osmani N, Lefebvre O, Goetz JG, Unal S, Akarsu NA, Radosavljevic M, Chenard M-P, Rialland F, Grain A, Bene M-C, Eveillard M, Vincent M, Guy J, Faivre L, Thauvin-Robinet C, Thevenon J, Myers K, Fleming MD, Shimamura A, Bottollier-Lemallaz E, Westhof E, Lengerke C, Isidor B, Bahram S. Mutations in signal recognition particle <em>SRP54</em> cause syndromic neutropenia with Shwachman-Diamond-like features. <span><span class="ref-journal">J Clin Invest. </span>2017;<span class="ref-vol">127</span>:4090–103.</span> [<a href="/pmc/articles/PMC5663364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5663364</span></a>] [<a href="/pubmed/28972538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28972538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.carvalho.2014.64">Carvalho CM, Zuccherato LW, Williams CL, Neill NJ, Murdock DR, Bainbridge M, Jhangiani SN, Muzny DM, Gibbs RA, Ip W, Guillerman RP, Lupski JR, Bertuch AA. Structural variation and missense mutation in SBDS associated with Shwachman-Diamond syndrome. <span><span class="ref-journal">BMC Med Genet. </span>2014;<span class="ref-vol">15</span>:64.</span> [<a href="/pmc/articles/PMC4057820/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4057820</span></a>] [<a href="/pubmed/24898207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24898207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.cesaro.2005.231">Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, Gluckman E, Bredius R, Boogaerts M, Vermylen C, Veys P, Marsh J, Badell I, Michel G, G&#x000fc;ng&#x000f6;r T, Niethammer D, Bordigoni P, Oswald C, Favre C, Passweg J, Dini G, et al.  Haematopoietic stem cell transplantation for Shwachman-Diamond disease; a study from the European Group for blood and marrow transplantation. <span><span class="ref-journal">Br J Haematol. </span>2005;<span class="ref-vol">131</span>:231–6.</span> [<a href="/pubmed/16197455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16197455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.cipolli.2001.543">Cipolli M. Shwachman-Diamond syndrome: clinical phenotypes. <span><span class="ref-journal">Pancreatology. </span>2001;<span class="ref-vol">1</span>:543–8.</span> [<a href="/pubmed/12120235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12120235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.cipolli.1999.265">Cipolli M, D'Orazio C, Delmarco A, Marchesini C, Miano A, Mastella G. Shwachman's syndrome: pathomorphosis and long-term outcome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>1999;<span class="ref-vol">29</span>:265–72.</span> [<a href="/pubmed/10467990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10467990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.costa.2007.96">Costa E, Duque F, Oliveira J, Garcia P, Gon&#x000e7;alves I, Diogo L, Santos R. Identification of a novel AluSx-mediated deletion of exon 3 in the SBDS gene in a patient with Shwachman-Diamond syndrome. <span><span class="ref-journal">Blood Cells Mol Dis. </span>2007;<span class="ref-vol">39</span>:96–101.</span> [<a href="/pubmed/17376717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17376717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.crescenzi.2009.116">Crescenzi B, La Starza R, Sambani C, Parcharidou A, Pierini V, Nofrini V, Brandimarte L, Matteucci C, Aversa F, Martelli MF, Mecucci C. Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome. <span><span class="ref-journal">Br J Haematol. </span>2009;<span class="ref-vol">144</span>:116–9.</span> [<a href="/pubmed/19016724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19016724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.cunningham.2002.1062">Cunningham J, Sales M, Pearce A, Howard J, Stallings R, Telford N, Wilkie R, Huntly B, Thomas A, O'Marcaigh A, Will A, Pratt N. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman-Diamond syndrome? <span><span class="ref-journal">Br J Haematol. </span>2002;<span class="ref-vol">119</span>:1062–9.</span> [<a href="/pubmed/12472589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12472589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dale.2006.220">Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K. The Severe Chronic Neutropenia International Registry: 10-year follow-up report. <span><span class="ref-journal">Support Cancer Ther. </span>2006;<span class="ref-vol">3</span>:220–31.</span> [<a href="/pubmed/18632498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18632498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dhanraj.2017.1557">Dhanraj S, Matveev A, Li H, Lauhasurayotin S, Jardine L, Cada M, Zlateska B, Tailor CS, Zhou J, Mendoza-Londono R, Vincent A, Durie PR, Scherer SW, Rommens JM, Heon E, Dror Y. Biallelic mutations in <em>DNAJC21</em> cause Shwachman-Diamond syndrome. <span><span class="ref-journal">Blood. </span>2017;<span class="ref-vol">129</span>:1557–62.</span> [<a href="/pubmed/28062395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28062395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.donadieu.2012.1312">Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N, Lambilliotte A, Aladjidi N, Bertrand Y, Mialou V, Perot C, Michel G, Fouyssac F, Paillard C, Gandemer V, Boutard P, Schmitz J, Morali A, Leblanc T, Bellann&#x000e9;-Chantelot C, et al.  Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">Haematologica. </span>2012;<span class="ref-vol">97</span>:1312–9.</span> [<a href="/pmc/articles/PMC3436231/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3436231</span></a>] [<a href="/pubmed/22491737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22491737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.donadieu.2005.787">Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B, Leverger G, Laporte JP, Hermine O, Buzyn A, Bertrand Y, Casanova JL, Leblanc T, Gluckman E, Fischer A, Stephan JL. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. <span><span class="ref-journal">Bone Marrow Transplant. </span>2005;<span class="ref-vol">36</span>:787–92.</span> [<a href="/pubmed/16151425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16151425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dror.2011.40">Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, Kerr E, Zeidler C, Shimamura A, Shah N, Cipolli M, Kuijpers T, Durie P, Rommens J, Siderius L, Liu JM. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2011;<span class="ref-vol">1242</span>:40–55.</span> [<a href="/pubmed/22191555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22191555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dror.1999.3048">Dror Y, Freedman MH. Shwachman-Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoetic progenitors and faulty microenvironment. <span><span class="ref-journal">Blood. </span>1999;<span class="ref-vol">94</span>:3048–54.</span> [<a href="/pubmed/10556188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10556188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dror.2002.701">Dror Y, Freedman MH. Shwachman-diamond syndrome. <span><span class="ref-journal">Br J Haematol. </span>2002;<span class="ref-vol">118</span>:701–13.</span> [<a href="/pubmed/12181037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12181037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.dror.2001.712">Dror Y, Ginzberg H, Dalal I, Cherepanov V, Downey G, Durie P, Roifman CM, Freedman MH. Immune function in patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">Br J Haematol. </span>2001;<span class="ref-vol">114</span>:712–7.</span> [<a href="/pubmed/11553003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11553003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.durie.2004">Durie PR, Rommens JM. Shwachman-Diamond syndrome. In: Walker WA, Goulet O, Kleinman RE, Sherman PM, Shneider BL, Sanderson IR, eds. <em>Pediatric Gastrointestinal Disease</em>. 4 ed. Lewiston, NY: BC Decker Inc; 2004:1624-33.</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.erdos.2006.1517">Erdos M, Alapi K, Balogh I, Oroszlan G, Rakoczi E, Sumegi J, Marodi L. Severe Shwachman-Diamond syndrome phenotype caused by compound heterozygous missense mutations in the SBDS gene. <span><span class="ref-journal">Exp Hematol. </span>2006;<span class="ref-vol">34</span>:1517–21.</span> [<a href="/pubmed/17046571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17046571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.finch.2011.917">Finch AJ, Hilcenko C, Basse N, Drynan LF, Goyenechea B, Menne TF, Gonz&#x000e1;lez Fern&#x000e1;ndez A, Simpson P, D'Santos CS, Arends MJ, Donadieu J, Bellann&#x000e9;-Chantelot C, Costanzo M, Boone C, McKenzie AN, Freund SM, Warren AJ. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. <span><span class="ref-journal">Genes Dev. </span>2011;<span class="ref-vol">25</span>:917–29.</span> [<a href="/pmc/articles/PMC3084026/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3084026</span></a>] [<a href="/pubmed/21536732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21536732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ganapathi.2007.1458">Ganapathi KA, Austin KM, Lee CS, Dias A, Malsch MM, Reed R, Shimamura A. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>:1458–65.</span> [<a href="/pmc/articles/PMC1975835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1975835</span></a>] [<a href="/pubmed/17475909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17475909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ginzberg.1999.81">Ginzberg H, Shin J, Ellis L, Morrison J, Ip W, Dror Y, Freedman M, Heitlinger LA, Belt MA, Corey M, Rommens JM, Durie PR. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">135</span>:81–8.</span> [<a href="/pubmed/10393609" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10393609</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.giri.2018">Giri N, Reed HD, Stratton P, Savage SA, Alter BP. Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2018;<span class="ref-vol">65</span>(1)</span> [<a href="/pubmed/28801981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28801981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.goobie.2001.1048">Goobie S, Popovic M, Morrison J, Ellis L, Ginzberg H, Boocock GR, Ehtesham N, Betard C, Brewer CG, Roslin NM, Hudson TJ, Morgan K, Fujiwara TM, Durie PR, Rommens JM. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:1048–54.</span> [<a href="/pmc/articles/PMC1275624/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1275624</span></a>] [<a href="/pubmed/11254457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11254457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.grinspan.2005.179">Grinspan ZM, Pikora CA. Infections in patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">Pediatr Infect Dis J. </span>2005;<span class="ref-vol">24</span>:179–81.</span> [<a href="/pubmed/15702050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15702050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.hashmi.2011.448">Hashmi SK, Allen C, Klaassen R, Fernandez CV, Yanofsky R, Shereck E, Champagne J, Silva M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Hand JP, Beyene J, Dror Y. Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">79</span>:448–58.</span> [<a href="/pubmed/20569259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20569259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.henson.2013.29">Henson AL, Moore JB, Alard P, Wattenberg MM, Liu JM, Ellis SR. Mitochondrial function is impaired in yeast and human cellular models of Shwachman Diamond syndrome. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2013;<span class="ref-vol">437</span>:29–34.</span> [<a href="/pubmed/23792098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23792098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ho.2007.52">Ho W, Cheretakis C, Durie P, Kulkarni G, Glogauer M. Prevalence of oral diseases in Shwachman-Diamond syndrome. <span><span class="ref-journal">Spec Care Dentist. </span>2007;<span class="ref-vol">27</span>:52–8.</span> [<a href="/pubmed/17539220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17539220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ip.2002.259">Ip WF, Dupuis A, Ellis L, Beharry S, Morrison J, Stormon MO, Corey M, Rommens JM, Durie PR. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">141</span>:259–65.</span> [<a href="/pubmed/12183724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12183724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.jivani.2016.1325">Jivani N, Torrado-Jule C, Vaiselbuh S, Romanos-Sirakis E. A unique case of Shwachman-Diamond syndrome presenting with congenital hypothyroidism. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2016;<span class="ref-vol">29</span>:1325–1327.</span> [<a href="/pubmed/27754968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27754968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.kent.1990.1349">Kent A, Murphy GH, Milla P. Psychological characteristics of children with Shwachman syndrome. <span><span class="ref-journal">Arch Dis Child. </span>1990;<span class="ref-vol">65</span>:1349–52.</span> [<a href="/pmc/articles/PMC1793082/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1793082</span></a>] [<a href="/pubmed/1702966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1702966</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.kerr.2010.433">Kerr EN, Ellis L, Dupuis A, Rommens JM, Durie PR. The behavioral phenotype of school-age children with Shwachman Diamond syndrome indicates neurocognitive dysfunction with loss of Shwachman-Bodian-Diamond syndrome gene function. <span><span class="ref-journal">J Pediatr. </span>2010;<span class="ref-vol">156</span>:433–8.</span> [<a href="/pubmed/19906387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19906387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.kuijpers.2005.356">Kuijpers TW, Alders M, Tool AT, Mellink C, Roos D, Hennekam RC. Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">106</span>:356–61.</span> [<a href="/pubmed/15769891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15769891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.mack.1996.1593">Mack DR, Forstner GG, Wilschanski M, Freedman MH, Durie PR. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. <span><span class="ref-journal">Gastroenterology. </span>1996;<span class="ref-vol">111</span>:1593–602.</span> [<a href="/pubmed/8942739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8942739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.majeed.2005.920">Majeed F, Jadko S, Freedman MH, Dror Y. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2005;<span class="ref-vol">45</span>:920–4.</span> [<a href="/pubmed/16007594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16007594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.m_kitie.2004.101">M&#x000e4;kitie O, Ellis L, Durie PR, Morrison JA, Sochett EB, Rommens JM, Cole WG. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. <span><span class="ref-journal">Clin Genet. </span>2004;<span class="ref-vol">65</span>:101–12.</span> [<a href="/pubmed/14984468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14984468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.maserati.2006.375">Maserati E, Minelli A, Pressato B, Valli R, Crescenzi B, Stefanelli M, Menna G, Sainati L, Poli F, Panarello C, Zecca M, Curto FL, Mecucci C, Danesino C, Pasquali F. Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2006;<span class="ref-vol">45</span>:375–82.</span> [<a href="/pubmed/16382447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16382447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.maserati.2009.190">Maserati E, Pressato B, Valli R, Minelli A, Sainati L, Patitucci F, Marletta C, Mastronuzzi A, Poli F, Lo Curto F, Locatelli F, Danesino C, Pasquali F. The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies. <span><span class="ref-journal">Br J Haematol. </span>2009;<span class="ref-vol">145</span>:190–7.</span> [<a href="/pubmed/19222471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19222471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.menne.2007.486">Menne TF, Goyenechea B, Sanchez-Puig N, Wong CC, Tonkin LM, Ancliff PJ, Brost RL, Costanzo M, Boone C, Warren AJ. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:486–95.</span> [<a href="/pubmed/17353896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17353896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.mitsui.2004.189">Mitsui T, Kawakami T, Sendo D, Katsuura M, Shimizu Y, Hayasaka K. Successful unrelated donor bone marrow transplantation for Shwachman-Diamond syndrome with leukemia. <span><span class="ref-journal">Int J Hematol. </span>2004;<span class="ref-vol">79</span>:189–92.</span> [<a href="/pubmed/15005350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15005350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.myers.2014.866">Myers KC, Bolyard AA, Otto B, Wong TE, Jones AT, Harris RE, Davies SM, Dale DC, Shimamura A. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. <span><span class="ref-journal">J Pediatr. </span>2014;<span class="ref-vol">164</span>:866–70.</span> [<a href="/pmc/articles/PMC4077327/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4077327</span></a>] [<a href="/pubmed/24388329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24388329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.myers.2013a.117">Myers KC, Davies SM, Shimamura A. Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. <span><span class="ref-journal">Hematol Oncol Clin North Am. </span>2013a;<span class="ref-vol">27</span>:117–28.</span> [<a href="/pmc/articles/PMC5693339/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5693339</span></a>] [<a href="/pubmed/23351992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23351992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.myers.2013b.1235">Myers KC, Rose SR, Rutter MM, Mehta PA, Khoury JC, Cole T, Harris RE. Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome. <span><span class="ref-journal">J Pediatr. </span>2013b;<span class="ref-vol">162</span>:1235–40.</span> [<a href="/pmc/articles/PMC5693331/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5693331</span></a>] [<a href="/pubmed/23305959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23305959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.nicolis.2005.410">Nicolis E, Bonizzato A, Assael BM, Cipolli M. Identification of novel mutations in patients with Shwachman-Diamond syndrome. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:410.</span> [<a href="/pubmed/15776428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15776428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.nishimura.2007.e73">Nishimura G, Nakashima E, Hirose Y, Cole T, Cox P, Cohn DH, Rimoin DL, Lachman RS, Miyamoto Y, Kerr B, Unger S, Ohashi H, Superti-Furga A, Ikegawa S. The Shwachman-Bodian-Diamond syndrome gene mutations cause a neonatal form of spondylometaphysial dysplasia (SMD) resembling SMD Sedaghatian type. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:e73.</span> [<a href="/pmc/articles/PMC2598034/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598034</span></a>] [<a href="/pubmed/17400792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17400792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.perobelli.2012.567">Perobelli S, Nicolis E, Assael BM, Cipolli M. Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:567–73.</span> [<a href="/pubmed/22315206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22315206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.pichler.2015.590">Pichler J, Meyer R, K&#x000f6;glmeier J, Ancliff P, Shah N. Nutritional status in children with Shwachman-Diamond syndrome. <span><span class="ref-journal">Pancreas. </span>2015;<span class="ref-vol">44</span>:590–5.</span> [<a href="/pubmed/25742431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25742431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.ritchie.2002.931">Ritchie DS, Angus PW, Bhathal PS, Grigg AP. Liver failure complicating non-alcoholic steatohepatitis following allogenic bone marrow transplantation for Shwachman-Diamond syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2002;<span class="ref-vol">29</span>:931–3.</span> [<a href="/pubmed/12080360" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12080360</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.rosenberg.2006.4628">Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman MA, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale D, et al.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4628–35.</span> [<a href="/pmc/articles/PMC1895804/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1895804</span></a>] [<a href="/pubmed/16497969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16497969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.rothbaum.2002.266">Rothbaum R, Perrault J, Vlachos A, Cipolli M, Alter BP, Burroughs S, Durie P, Elghetany MT, Grand R, Hubbard V, Rommens J, Rossi T. Shwachman-Diamond syndrome: report from an international conference. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">141</span>:266–70.</span> [<a href="/pubmed/12183725" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12183725</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.rothbaum.1982.800">Rothbaum RJ, Williams DA, Daugherty CC. Unusual surface distribution of concanavalin A reflects a cytoskeletal defect in neutrophils in Shwachman's syndrome. <span><span class="ref-journal">Lancet. </span>1982;<span class="ref-vol">2</span>:800–1.</span> [<a href="/pubmed/6181360" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6181360</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.sack.2011.568">Sack JE, Kuchnir L, Demierre M-F. Dermatofibrosarcoma protuberans arising in the context of Shwachman-Diamond syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2011;<span class="ref-vol">28</span>:568–9.</span> [<a href="/pubmed/21073512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21073512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.sauer.2007.143">Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Weltke K, Lohse P, Sykora KW. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2007;<span class="ref-vol">39</span>:143–7.</span> [<a href="/pubmed/17211437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17211437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.savchenko.2005.19213">Savchenko A, Krogan N, Cort JR, Evdokimova E, Lew JM, Yee AA, Sanchez-Pulido L, Andrade MA, Bochkarev A, Watson JD, Kennedy MA, Greenblatt J, Hughes T, Arrowsmith CH, Rommens JM, Edwards AM. The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolism. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:19213–20.</span> [<a href="/pubmed/15701634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15701634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.schibli.2006.90">Schibli S, Corey M, Gaskin KJ, Ellis L, Durie PR. Towards an ideal quantitative pancreatic function test: analysis of test variables that influence validity. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:90–7.</span> [<a href="/pubmed/16431310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16431310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.shah.2010.592">Shah N, Cambrook H, Koglmeier J, Mason C, Ancliff P, Lindley K, Smith VV, Bajaj-Elliott M, Sebire NJ. Enteropathic histopathological features may be associated with Shwachman-Diamond syndrome. <span><span class="ref-journal">J Clin Pathol. </span>2010;<span class="ref-vol">63</span>:592–4.</span> [<a href="/pubmed/20501449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20501449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.shammas.2005.19221">Shammas C, Menne TF, Hilcenko C, Michell SR, Goyenechea B, Boocock GR, Durie PR, Rommens JM, Warren AJ. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman-Diamond Syndrome. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:19221–9.</span> [<a href="/pubmed/15701631" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15701631</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.shankar.2017.458">Shankar RK, Giri N, Lodish MB, Sinaii N, Reynolds JC, Savage SA, Stratakis CA, Alter BP. Bone mineral density in patients with inherited bone marrow failure syndromes. <span><span class="ref-journal">Pediatr Res. </span>2017;<span class="ref-vol">82</span>:458–64.</span> [<a href="/pmc/articles/PMC5570650/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5570650</span></a>] [<a href="/pubmed/28486441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28486441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.sharma.2014.564">Sharma A, Sadimin E, Drachtman R, Glod J. CNS lymphoma in a patient with Shwachman Diamond syndrome. <span><span class="ref-journal">Pediatric Blood &#x00026; Cancer. </span>2014;<span class="ref-vol">61</span>:564–6.</span> [<a href="/pubmed/24307640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24307640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.singh.2012.945">Singh SA, Vlachos A, Morgenstern NJ, Ouansafi I, Ip W, Rommens JM, Durie P, Shimamura A, Lipton JM. Breast cancer in a case of Shwachman Diamond syndrome. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2012;<span class="ref-vol">59</span>:945–6.</span> [<a href="/pubmed/22213587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22213587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.smith.1996.279">Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P. Haematological abnormalities in Shwachman-Diamond syndrome. <span><span class="ref-journal">Br J Haematol. </span>1996;<span class="ref-vol">94</span>:279–84.</span> [<a href="/pubmed/8759887" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8759887</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.steele.2014">Steele L, Rommens JM, Stockley T, Berivan Baskin B, Ray PN. De novo mutations causing Shwachman-Diamond syndrome and a founder mutation in SBDS in the French Canadian population. J Invest Genom. Available <a href="http://www.google.com/url?sa=t&#x00026;rct=j&#x00026;q=&#x00026;esrc=s&#x00026;source=web&#x00026;cd=2&#x00026;ved=0CCcQFjAB&#x00026;url=http%3A%2F%2Fmedcraveonline.com%2FJIG%2FJIG-01-00008.pdf&#x00026;ei=dEcHVKapDqG1iwKu-4H4BQ&#x00026;usg=AFQjCNFNXW_MyVsnLxpyKrnpAodvSoFeBg&#x00026;sig2=SneF2iNO7m0pc1ANbsc0AA&#x00026;bvm=bv.74115972,d.cGE&#x00026;cad=rja" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2014. Accessed 10-11-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.stepanovic.2004.158">Stepanovic V, Wessels D, Goldman FD, Geiger J, Soll DR. The chemotaxis defect of Shwachman-Diamond syndrome leukocytes. <span><span class="ref-journal">Cell Motil Cytoskeleton. </span>2004;<span class="ref-vol">57</span>:158–74.</span> [<a href="/pubmed/14743349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14743349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.stepensky.2017.558">Stepensky P, Chacon-Flores M, Kim KH, Abuzaitoun O, Bautista-Santos A, Simanovsky N, Siliqi D, Altamura D, Mendez-Godoy A, Gijsbers A, Eddin AN, Dor T, Charrow J, Sanchez-Puig N, Elpeleg O. Mutations in <em>ELF1</em>, an <em>SBDS</em> partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome. <span><span class="ref-journal">J Med Genet. </span>2017;<span class="ref-vol">54</span>:558–66.</span> [<a href="/pubmed/28331068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28331068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.stormon.2010.8">Stormon MO, Ip WF, Ellis L, Schibli S, Rommens JM, Durie PR. Evidence of a generalized defect of acinar cell function in Shwachman-Diamond syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2010;<span class="ref-vol">51</span>:8–13.</span> [<a href="/pubmed/20512054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20512054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.tamary.2010.1300">Tamary H, Nishri D, Yacobovich J, Zilber R, Dgany O, Krasnov T, Aviner S, Stepensky P, Ravel-Vilk S, Bitan M, Kaplinsky C, Ben Barak A, Elhasid R, Kapelusnik J, Koren A, Levin C, Attias D, Laor R, Yaniv I, Rosenberg PS, Alter BP. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>:1300–7.</span> [<a href="/pmc/articles/PMC2913078/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2913078</span></a>] [<a href="/pubmed/20435624" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20435624</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.taneichi.2006.60">Taneichi H, Kanegane H, Futatani T, Otsubo K, Nomura K, Sato Y, Hama A, Kojima S, Kohdera U, Nakano T, Hori H, Kawashima H, Inoh Y, Kamizono J, Adachi N, Osugi Y, Mizuno H, Hotta N, Yoneyama H, Nakashima E, Ikegawa S, Miyawaki T. Clinical and genetic analyses of presumed Shwachman-Diamond syndrome in Japan. <span><span class="ref-journal">Int J Hematol. </span>2006;<span class="ref-vol">84</span>:60–2.</span> [<a href="/pubmed/16867904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16867904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.toiviainensalo.2009.807">Toiviainen-Salo S, Durie PR, Numminen K, Heikkila P, Marttinen E, Savilahti E, Makitie O. The natural history of Shwachman-Diamond syndrome-associated liver disease from childhood to adulthood. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">155</span>:807–811.e2.</span> [<a href="/pubmed/19683257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19683257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.toiviainensalo.2008a.1558">Toiviainen-Salo S, Makitie O, Mannerkoski M, Hamalainen J, Valanne L, Autti T. Shwachman-Diamond syndrome is associated with structural brain alterations on MRI. <span><span class="ref-journal">Am J Med Genet A. </span>2008a;<span class="ref-vol">146A</span>:1558–64.</span> [<a href="/pubmed/18478597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18478597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.toiviainensalo.2007.965">Toiviainen-Salo S, M&#x000e4;yr&#x000e4;np&#x000e4;&#x000e4; MK, Durie PR, Richards N, Grynpas M, Ellis L, Ikegawa S, Cole WG, Rommens J, Marttinen E, Savilahti E, M&#x000e4;kitie O. Shwachman-Diamond syndrome is associated with low-turnover osteoporosis. <span><span class="ref-journal">Bone. </span>2007;<span class="ref-vol">41</span>:965–72.</span> [<a href="/pubmed/17920346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17920346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.toiviainensalo.2008b.434">Toiviainen-Salo S, Raade M, Durie PR, Ip W, Marttinen E, Savilahti E, M&#x000e4;kitie O. Magnetic resonance imaging findings of the pancreas in patients with Shwachman-Diamond syndrome and mutations in the SBDS gene. <span><span class="ref-journal">J Pediatr. </span>2008b;<span class="ref-vol">152</span>:434–6.</span> [<a href="/pubmed/18280855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18280855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.valli.2017.e26454">Valli R, De Paoli E, Nacci L, Frattini A, Pasquali F, Maserati E. Novel recurrent chromosome anomalies in Shwachman-Diamond syndrome. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2017;<span class="ref-vol">64</span>:e26454.</span> [<a href="/pubmed/28130858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28130858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.venet.2017.1660">Venet T, Masson E, Talbotec C, Billiemaz K, Touraine R, Gay C, Destombe S, Cooper DN, Patural H, Chen JM, F&#x000e9;rec C. Severe infantile isolated exocrine pancreatic insufficiency caused by the complete functional loss of the SPINK1 gene. <span><span class="ref-journal">Hum Mutat. </span>2017;<span class="ref-vol">38</span>:1660–5.</span> [<a href="/pubmed/28945313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28945313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.vibhakar.2005.855">Vibhakar R, Radhi M, Rumelhart S, Tatman D, Goldman F. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2005;<span class="ref-vol">36</span>:855–61.</span> [<a href="/pubmed/16113664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16113664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sds.REF.zhang.2006.6656">Zhang S, Shi M, Hui CC, Rommens JM. Loss of the mouse ortholog of the Shwachman-Diamond syndrome gene (Sbds) results in early embryonic lethality. <span><span class="ref-journal">Mol Cell Biol. </span>2006;<span class="ref-vol">26</span>:6656–63.</span> [<a href="/pmc/articles/PMC1592835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1592835</span></a>] [<a href="/pubmed/16914746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16914746</span></a>]</div></li></ul></div></div><div id="sds.Chapter_Notes"><h2 id="_sds_Chapter_Notes_">Chapter Notes</h2><div id="sds.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank individuals with Shwachman-Diamond syndrome and their families and care givers, as well as Dr Peter Durie, Dr Akiko Shimamura, and Dr Stella Davies.</p></div><div id="sds.Author_History"><h3>Author History</h3><p>Peter R Durie, MD, FRCPC; University of Toronto (2008-2014)<br />Kasiani Myers, MD (2014-present)<br />Johanna M Rommens, PhD; University of Toronto (2008-2014)</p></div><div id="sds.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 October 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 July 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>7 January 2008 (jr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1756</span><span class="label">PMID: <a href="/pubmed/20301722" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301722</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sgs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sft/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1756&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1756/?report=reader">PubReader</a></li><li><a href="/books/NBK1756/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1756" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1756" style="display:none" title="Cite this Page"><div class="bk_tt">Nelson A, Myers K. Shwachman-Diamond Syndrome. 2008 Jul 17 [Updated 2018 Oct 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1756/pdf/Bookshelf_NBK1756.pdf">PDF version of this page</a> (551K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sds.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sds.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sds.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sds.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sds.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sds.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sds.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sds.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sds.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sds.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sds.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=134218[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DNAJC21</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6729[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SRP54</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79631[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EFL1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=51119[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SBDS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1756+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1474732" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1474732" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1474732" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1474732" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301769" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clinton C, Gazda HT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30413969" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.</a><span class="source">[Mol Diagn Ther. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bezzerri V, Cipolli M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Diagn Ther. 2019 Apr; 23(2):281-290. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301287" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autoimmune Lymphoproliferative Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autoimmune Lymphoproliferative Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleesing JJH, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301705" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ELANE</i>-Related Neutropenia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ELANE</i>-Related Neutropenia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dale DC, Makaryan V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301722" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301722" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc850675f66d18aa221ea8">Shwachman-Diamond Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Shwachman-Diamond Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:23:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BE092DFC77C910000000005E402C1&amp;ncbi_session=CE8BE092DFC85051_1508SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1756%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1756&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1756/&amp;ncbi_pagename=Shwachman-Diamond Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BE092DFC85051_1508SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>